From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Tom Winnifrith Bearcast: Explaining with hard data and FACTS why Zoetic shares will collapse from 63.5p to buttons

By Tom Winnifrith | Saturday 8 May 2021


Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


I thank those who have been so generous so far but if you have not yet donated to Rogue Bloggers for Woodlarks then consider a fat middle-aged man walking 27 miles in the Cheshire rain tomorrow and please give a few quid HERE. In this podcast, I look at one company, at hard facts about its share ownership, about its sales, about what it has not said and at peer group valuation analysis. At the end of it all, I challenge anyone to disagree with the conclusion that the shares will collapse over the coming months from 63.5p to buttons. Re the declaration, the share I own is Imperial Brands (IMB).

You must be a paid subscriber to listen to Bearcast
ShareProphets is reader-supported journalism

Join us for free and gain access to three articles per month

Or become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 17:51:15